Elizabethkingia anophelis strain EM361-97 was isolated from the blood of a 46-year-old male patient with advanced nasopharyngeal carcinoma and lung cancer. During admission, the patient suffered from pneumonia, respiratory failure, and profound shock. He initially received empirical antibiotics with levofloxacin. Unfortunately, the patient died several days after this infection. One blood culture from the patient yielded a gram-negative bacillus that was initially identified as E. meningoseptica using API/ID32 GN (bioMérieux S.A., Marcy l’Etoile, France) by the clinical microbiology laboratory. This isolate was named strain EM361-97 and was stored at −80 °C as a glycerol stock for further experiments. We re-identified this isolate as E. anophelis using 16S ribosomal RNA (rRNA) gene sequencing as previously published15 (link). The minimum inhibitory concentration (MIC) of this isolate was examined using the broth microdilution method. The susceptibilities were determined according to the interpretive standards for “other non-Enterobacteriaceae” as suggested by the Clinical and Laboratory Standards Institute (CLSI) guidelines16 .
Api id32 gn
The API/ID32 GN is a manual microbiology identification system for the identification of Gram-negative bacilli. It provides a standardized, miniaturized, and easy-to-use format for the biochemical identification of a wide range of Gram-negative bacteria.
Lab products found in correlation
3 protocols using api id32 gn
Isolation and Characterization of Elizabethkingia anophelis
Elizabethkingia anophelis strain EM361-97 was isolated from the blood of a 46-year-old male patient with advanced nasopharyngeal carcinoma and lung cancer. During admission, the patient suffered from pneumonia, respiratory failure, and profound shock. He initially received empirical antibiotics with levofloxacin. Unfortunately, the patient died several days after this infection. One blood culture from the patient yielded a gram-negative bacillus that was initially identified as E. meningoseptica using API/ID32 GN (bioMérieux S.A., Marcy l’Etoile, France) by the clinical microbiology laboratory. This isolate was named strain EM361-97 and was stored at −80 °C as a glycerol stock for further experiments. We re-identified this isolate as E. anophelis using 16S ribosomal RNA (rRNA) gene sequencing as previously published15 (link). The minimum inhibitory concentration (MIC) of this isolate was examined using the broth microdilution method. The susceptibilities were determined according to the interpretive standards for “other non-Enterobacteriaceae” as suggested by the Clinical and Laboratory Standards Institute (CLSI) guidelines16 .
Comprehensive Characterization of Novel Bacterium
Comprehensive Bacterial Characterization Workflow
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!